StemRIM
4599
Rank in Stocks
#23107
StemRIM is a biotechnology firm dedicated to developing regenerative medicines... StemRIM is a biotechnology firm dedicated to developing regenerative medicines aimed at treating severe and challenging diseases. Its product pipeline includes PJ1, a regeneration-inducing medicine based on HMGB1 peptides, which is currently undergoing Phase II clinical trials for a range of conditions such as epidermolysis bullosa, cerebral infarction, osteoarthritis, chronic liver disease, and cardiomyopathy. Beyond PJ1, StemRIM is also advancing PJ2, another regeneration-inducing medicine utilizing novel peptides A and B; PJ3, a biologic protein designed to promote regeneration; PJ4, a device for collecting a patient's own cells for therapeutic purposes; and PJ5, a stem cell-based gene therapy. Established in 2006, StemRIM is headquartered in Ibaraki, Japan.
Share Price
$0.72791031
Last synced: 2026-11-10
Market Cap
$45.63M
Change (1 day)
-0.86%
Change (1 year)
-59.66%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade StemRIM (4599)
Category
Healthcare
EPS for StemRIM (4599)
EPS as of July 2026 TTM: $-0.19
According to StemRIM's latest financial reports, its current EPS (TTM) is $-0.19. At the end of 2025 the company had an EPS of $-0.21, an increase over its 2024 EPS of $-0.22.
EPS history for StemRIM from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.19 | -10.48% |
| 2025 | $-0.21 | -5.87% |
| 2024 | $-0.22 | -1,215.23% |
| 2023 | $0.02 | -107.98% |
| 2022 | $-0.25 | 170.32% |
| 2021 | $-0.09 | -250.16% |
| 2020 | $0.06 | -148.06% |
| 2019 | $-0.13 | 119.62% |
| 2018 | $-0.06 | 158.30% |
| 2017 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -8,429.79% |
US
|
|
| $-7.07 | 3,660.64% |
US
|
|
| $-5.29 | 2,713.83% |
AU
|
|
| $12.88 | -6,951.12% |
BE
|
|
| $21.56 | -11,568.09% |
NL
|
Questions about StemRIM's earnings per share (EPS)
What is StemRIM's earnings per share (EPS)?
StemRIM's earnings per share (EPS) over the last twelve months is $-0.19, as of Jul 2026.
What was StemRIM's earnings per share (EPS) in 2025?
In 2025, StemRIM's earnings per share (EPS) was $-0.21, compared with $-0.22 in 2024.
How has StemRIM's earnings per share (EPS) changed since 2020?
From 2020 to 2025, StemRIM's earnings per share (EPS) was highest in 2020 ($0.06) and lowest in 2022 ($-0.25).
How does StemRIM's earnings per share (EPS) compare with similar companies?
StemRIM's earnings per share (EPS) ($-0.19) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.